(HALLMARK | HALLMARKS) OF CANCER

/ Uncategorized / By
  1. The hallmarks of cancer
  2. Revisiting the hallmarks of cancer
  3. Hallmarks of cancer: the next generation
  4. What are the hallmarks of cancer?
  5. Hallmarks of cancer: new dimensions
  6. The hallmarks of cancer
  7. Wnts and the hallmarks of cancer
  8. Hallmarks of cancer: of all cancer cells, all the time?
  9. Hallmarks of cancer—the new testament
  10. Simulating the hallmarks of cancer
  11. The emerging hallmarks of cancer metabolism
  12. Evolutionary mechanism unifies the hallmarks of cancer
  13. Biological hallmarks of cancer
  14. Exploiting the hallmarks of cancer: the future conquest of breast cancer
  15. Exercise and the hallmarks of cancer
  16. The extracellular matrix modulates the hallmarks of cancer
  17. The hallmarks of cancer are also the hallmarks of wound healing
  18. Ion channels and the hallmarks of cancer
  19. MicroRNAs and the hallmarks of cancer
  20. NRF2 and the Hallmarks of Cancer
  21. Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy
  22. Hallmarks of cancer: interactions with the tumor stroma
  23. Imaging hallmarks of cancer in living mice
  24. Epigenetic plasticity and the hallmarks of cancer
  25. Sp1 and the ‘hallmarks of cancer’
  26. Hallmarks of cancer and hallmarks of aging
  27. An update to hallmarks of cancer
  28. The hallmarks of cancer metabolism: Still emerging
  29. Endoplasmic reticulum stress and the hallmarks of cancer
  30. The microbiome and the hallmarks of cancer
  31. The systemic hallmarks of cancer
  32. Hallmarks of cancer stem cell metabolism
  33. Transforming growth factor-β and the hallmarks of cancer
  34. Dual role of autophagy in hallmarks of cancer
  35. Mitochondria and the hallmarks of cancer
  36. Impact of immune cells on the hallmarks of cancer: A literature review
  37. Hallmarks of cancer and AU‐rich elements
  38. The hallmarks of cancer from a redox perspective
  39. The Warburg effect and the hallmarks of cancer
  40. Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
  41. The hallmarks of cancer: a long non-coding RNA point of view
  42. Molecular principles of metastasis: a hallmark of cancer revisited
  43. Hallmarks of cancer: The CRISPR generation
  44. Emerging concepts linking obesity with the hallmarks of cancer
  45. Lipid mechanisms in hallmarks of cancer
  46. Revisiting the hallmarks of cancer: The role of hyaluronan
  47. Autophagy and hallmarks of cancer
  48. Telomerase: central regulator of all of the hallmarks of cancer
  49. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
  50. Heparanase and the hallmarks of cancer
  51. The aging of the 2000 and 2011 Hallmarks of Cancer reviews: a critique
  52. Effects of animal venoms and toxins on hallmarks of cancer
  53. Epigenetic mechanisms and the hallmarks of cancer: An intimate affair
  54. The hallmarks of cancer as ecologically driven phenotypes
  55. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
  56. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
  57. Cancer secretomes and their place in supplementing other hallmarks of cancer
  58. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers
  59. From the modeling of the immune hallmarks of cancer to a black swan in biology
  60. Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer
  61. PPAR beta/delta and the hallmarks of cancer
  62. Mechanisms of cancer cell dormancy—another hallmark of cancer?
  63. Genomic instability—an evolving hallmark of cancer
  64. The relationship of redox with hallmarks of cancer: the importance of homeostasis and context
  65. The contribution of tumour-derived exosomes to the hallmarks of cancer
  66. The calcium-sensing receptor and the hallmarks of cancer
  67. Biological hallmarks of cancer in Alzheimer’s disease
  68. 2011: the immune hallmarks of cancer
  69. The role of miR-200 family in the regulation of hallmarks of cancer
  70. The renin-angiotensin system meets the hallmarks of cancer
  71. The effects of localized heat on the hallmarks of cancer
  72. Gold from the sea: marine compounds as inhibitors of the hallmarks of cancer
  73. Hallmarks of glycosylation in cancer
  74. Carotenoids modulate the hallmarks of cancer cells
  75. The role of extracellular vesicles in the hallmarks of cancer and drug resistance
  76. The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
  77. Automatic semantic classification of scientific literature according to the hallmarks of cancer
  78. Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer
  79. The Hallmarks of a Cancer Discovery
  80. Impact of ERK5 on the Hallmarks of Cancer
  81. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer
  82. Hallmarks of cancer progression in Barrett’s oesophagus
  83. The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology
  84. Hallmarks of cancer-related newly prognostic factors of oral squamous cell carcinoma
  85. Hallmarks of cancer: the insulin-like growth factors perspective
  86. Purinergic signaling in the hallmarks of cancer
  87. Chemokine receptor signaling and the hallmarks of cancer
  88. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
  89. The radiation-induced bystander effect (RIBE) and its connections with the hallmarks of cancer
  90. Glycosylation: a hallmark of cancer?
  91. ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance
  92. β1 integrins as therapeutic targets to disrupt hallmarks of cancer
  93. Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
  94. The role of transcription factors in the acquisition of the four latest proposed hallmarks of cancer and corresponding enabling characteristics
  95. Peroxisome proliferator-activated receptors and the hallmarks of cancer
  96. Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism
  97. Linking the history of radiation biology to the hallmarks of cancer
  98. The COX-2/PGE 2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
  99. Homeobox gene deregulation: impact on the hallmarks of cancer
  100. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer
  101. CK2 and the Hallmarks of Cancer
  102. Roles of NRF3 in the hallmarks of cancer: proteasomal inactivation of tumor suppressors
  103. The key characteristics of carcinogens: relationship to the hallmarks of cancer, relevant biomarkers, and assays to measure them
  104. MYC activation is a hallmark of cancer initiation and maintenance
  105. DNA replication stress as a hallmark of cancer
  106. Peto’s paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer
  107. Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer
  108. NRF2 and the Hallmarks of Cancer.
  109. PBX1: a key character of the hallmarks of cancer
  110. Vessel abnormalization: another hallmark of cancer?: molecular mechanisms and therapeutic implications
  111. Targeting hallmarks of cancer with a food-system–based approach
  112. Power from the garden: plant compounds as inhibitors of the hallmarks of cancer
  113. Cell immortality and hallmarks of cancer
  114. Pro-survival autophagy: An emerging candidate of tumor progression through maintaining hallmarks of cancer
  115. Pan‐cancer RNA‐seq data stratifies tumours by some hallmarks of cancer
  116. RAGE and its ligands: molecular interplay between glycation, inflammation, and hallmarks of cancer—a review
  117. Mutant p53 gain of function is interwoven into the hallmarks of cancer
  118. Invasion and metastasis: the elusive hallmark of cancer
  119. The power behind the throne: senescence and the hallmarks of cancer
  120. Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression
  121. The cellular prion protein and the hallmarks of cancer
  122. Hallmarks of cancer affected by the MIF cytokine family
  123. Nanomaterials for oncotherapies targeting the hallmarks of cancer
  124. Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
  125. Aberrant alternative splicing is another hallmark of cancer
  126. A Pan-Cancer Atlas of Differentially Interacting Hallmarks of Cancer Proteins
  127. The enigmatic helicase DHX9 and its association with the hallmarks of cancer
  128. 150th anniversary series: desmosomes and the hallmarks of cancer
  129. Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer
  130. Chalcones against the hallmarks of cancer: A mini-review
  131. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma
  132. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: key roles in the hallmarks of cancer
  133. Glutaminolysis: a hallmark of cancer metabolism
  134. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
  135. Zinc finger proteins and regulation of the hallmarks of cancer
  136. STIM and ORAI proteins: crucial roles in hallmarks of cancer
  137. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer
  138. ASCT2 and LAT1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation
  139. Intricate crosstalk between MYC and non‐coding RNA s regulates hallmarks of cancer
  140. The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer
  141. The chemopreventive activity of Indonesia medicinal plants targeting on hallmarks of cancer
  142. The PARP enzyme family and the hallmarks of cancer part 1. cell intrinsic hallmarks
  143. The functional hallmarks of cancer predisposition genes
  144. Molecular mechanisms of anti-cancer activities of β-elemene: targeting hallmarks of cancer
  145. Hallmarks of alternative splicing in cancer
  146. Genetic and biological hallmarks of colorectal cancer
  147. Phytosterols and phytostanols and the hallmarks of cancer in model organisms: A systematic review and meta-analysis
  148. Aberrant regulation of miR-15b in human malignant tumors and its effects on the hallmarks of cancer
  149. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer
  150. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
  151. Treatment for patients with malignant pheochromocytomas and paragangliomas: a perspective from the hallmarks of cancer
  152. The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis
  153. Meta-hallmarks of aging and cancer
  154. Natural antisense transcripts in the biological hallmarks of cancer: powerful regulators hidden in the dark
  155. Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
  156. The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer
  157. The parp enzyme family and the hallmarks of cancer part 2: hallmarks related to cancer host interactions
  158. Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer
  159. Converging technologies: targeting the hallmarks of cancer using ultrasound and microbubbles
  160. The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities
  161. MicroRNAs: novel regulators in the hallmarks of human cancer
  162. The biological implications of Yin Yang 1 in the hallmarks of cancer
  163. Roles of p53, MYC and HIF-1 in regulating glycolysis—the seventh hallmark of cancer
  164. Adipose tissue-derived extracellular vesicles and the tumor microenvironment: revisiting the hallmarks of cancer
  165. Hallmarks of cancer: A 2012 perspective
  166. The remodelling of actin composition as a hallmark of cancer
  167. Cancer stem cells in solid tumors: Is ‘evading apoptosis’a hallmark of cancer?
  168. Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer
  169. Tumor acidity: From hallmark of cancer to target of treatment
  170. The hallmarks of flavonoids in cancer
  171. Current status of mathematical modeling of cancer–from the viewpoint of cancer hallmarks
  172. Polymorphic microbes: A new emerging hallmark of cancer
  173. Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews
  174. Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses
  175. Role of hypoxia in the hallmarks of human cancer
  176. Establishing a consensus for the hallmarks of cancer based on gene ontology and pathway annotations
  177. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer …
  178. Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis
  179. Hallmarks of cancer. An organizing principle for cancer medicine
  180. Targeting the hallmarks of cancer: The effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer
  181. Ancient genes establish stress-induced mutation as a hallmark of cancer
  182. Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective
  183. RNA splicing dysregulation and the hallmarks of cancer
  184. The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors
  185. The hallmarks of premalignant conditions: a molecular basis for cancer prevention
  186. Expression profile of MicroRNA: an emerging hallmark of cancer
  187. The NRSF/REST transcription factor in hallmarks of cancer: From molecular mechanisms to clinical relevance
  188. Nanoparticle based combination treatments for targeting multiple hallmarks of cancer
  189. Overexpression of the base excision repair NTHL1 glycosylase causes genomic instability and early cellular hallmarks of cancer
  190. The RNA interactome in the Hallmarks of Cancer
  191. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer
  192. Translational control of aberrant stress responses as a hallmark of cancer
  193. The” two-faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer
  194. ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer
  195. A systematic approach toward gene annotation of the hallmarks of cancer
  196. IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
  197. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
  198. The hallmarks of CDKN1C (p57, KIP2) in cancer
  199. The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer
  200. Filling the gap between chemical carcinogenesis and the hallmarks of cancer: a temporal perspective
  201. Reprogrammed lipid metabolism and the lipid-associated hallmarks of colorectal cancer
  202. The hallmarks of breast cancer by Raman spectroscopy
  203. The hallmarks of cancer… in pituitary tumors?
  204. Sirtuin-3 (SIRT3) and the Hallmarks of Cancer
  205. Resistance to apoptosis should not be taken as a hallmark of cancer
  206. Hallmarks of cancer in the reading room: a guide for radiologists
  207. … modeling framework linking inflammation and cancer using evolutionary principles: Description of a generative hierarchy for the hallmarks of cancer and developing a …
  208. Plasmonic Biosensing for Label-Free Detection of Two Hallmarks of Cancer Cells: Cell-Matrix Interaction and Cell Division
  209. FBXW7 and the hallmarks of cancer: Underlying mechanisms and prospective strategies
  210. The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer
  211. The fungal mycobiome: A new hallmark of cancer revealed by pan-cancer analyses
  212. Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development
  213. Interactions of circadian clock genes with the hallmarks of cancer
  214. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
  215. Microbiome and the Hallmarks of Cancer
  216. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF‐κΒ/STAT3 signalling axis in oral squamous cell carcinoma models
  217. Chemoresistance and cancer-related inflammation: two hallmarks of cancer connected by an atypical link, PKCζ
  218. Targeting the hallmarks of cancer
  219. Circulating ensembles of tumor‐associated cells: a redoubtable new systemic hallmark of cancer
  220. Dissecting the oncogenic roles of keratin 17 in the hallmarks of cancer
  221. lncRNAs in hallmarks of cancer and clinical applications
  222. Drosophila and the Hallmarks of Cancer
  223. Are short telomeres hallmarks of cancer recurrence?
  224. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour
  225. Escaping circadian regulation: an emerging hallmark of cancer?
  226. CancerSim: A computer-based simulation of Hanahan and Weinberg’s Hallmarks of Cancer
  227. Long non-coding RNAs regulate the hallmarks of cancer in HPV-induced malignancies
  228. TP53: Coordinator of the Processes That Underlie the Hallmarks of Cancer
  229. G-protein–coupled receptor kinase 2 as a potential modulator of the hallmarks of cancer
  230. In-depth serum proteomics reveals the trajectory of hallmarks of cancer in hepatitis B virus-related liver diseases
  231. The Critical Role of RNA m6A Methylation in Gliomas: Targeting the Hallmarks of Cancer
  232. Hallmark of cancer: Reprogramming of cellular metabolism
  233. Transcriptional hallmarks of cancer cell lines reveal an emerging role of branched chain amino acid catabolism
  234. Inference of low and high-grade glioma gene regulatory networks delineates the role of Rnd3 in establishing multiple hallmarks of cancer
  235. Proteomics Reveals Cell‐Surface Urokinase Plasminogen Activator Receptor Expression Impacts Most Hallmarks of Cancer
  236. A brief review of the biophysical hallmarks of metastatic cancer cells
  237. The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
  238. Hallmarks of Cancer: Molecular Underpinnings
  239. tugHall: a simulator of cancer-cell evolution based on the hallmarks of cancer and tumor-related genes
  240. The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis—ten years later
  241. Molecular and cellular processes underlying the hallmarks of head and neck cancer
  242. Sweet cherry extract targets the hallmarks of cancer in prostate cells: Diminished viability, increased apoptosis and suppressed glycolytic metabolism
  243. Emerging role of mRNA methylation in regulating the hallmarks of cancer
  244. The Nervous System as a Regulator of Cancer Hallmarks: Insights into Therapeutic Implications
  245. Revisiting the hallmarks of cancer: a new look at long noncoding RNAs in breast cancer
  246. The Hallmarks of Cancer
  247. Targeting the hallmarks of ovarian cancer: The big picture
  248. Beyond bad luck: induced mutations and hallmarks of cancer
  249. An Update to Hallmarks of Cancer
  250. Hallmarks of Cancer: Its Concept and Critique
  251. A New Hallmark of Cancer: Stemness
  252. MIX2: a novel natural multi-component modulator of multidrug-resistance and hallmarks of cancer cells
  253. Cancer-specific therapeutic potential of resveratrol: metabolic approach against hallmarks of cancer
  254. Hallmarks of cancer
  255. Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity
  256. Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer
  257. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo
  258. Multi-drug resistant bacteria from Kolkata Ganga River with heterogeneous MDR genes have four hallmarks of cancer cells but could be controlled by organic …
  259. Notch signaling in the prostate: Critical roles during development and in the hallmarks of prostate cancer biology
  260. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma
  261. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue
  262. HPV vaccines can be the hallmark of cancer prevention
  263. The hallmarks of ovarian cancer: proliferation and cell growth
  264. A novel roadmap connecting the 1H-MRS total choline resonance to all hallmarks of cancer following targeted therapy
  265. New cancer diagnostics and therapeutics from a ninth ‘hallmark of cancer’: symmetric self-renewal by mutated distributed stem cells
  266. Multi-class BCGA-ELM based classifier that identifies biomarkers associated with hallmarks of cancer
  267. Physical exercise and the hallmarks of breast cancer: A narrative review
  268. HypoxaMIRs: key regulators of hallmarks of colorectal cancer
  269. Novel functions of cytoplasmic aminoacyl-tRNA synthetases shaping the hallmarks of cancer
  270. Targeting the latest hallmark of cancer: another attempt at ‘magic bullet’drugs targeting cancers’ metabolic phenotype
  271. The hallmarks of cancer and immunology
  272. Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma
  273. The hallmarks of cancer and their therapeutic targeting in current use and clinical trials
  274. Hallmark of cancer: Resisting cell death
  275. The emerging roles of long noncoding RNAs as hallmarks of lung cancer
  276. Hallmark of cancer: replicative immortality
  277. Gastrointestinal tumors: phytochemical and drug combinations targeting the hallmarks of cancer
  278. Dysregulation of Mg2+ homeostasis contributes to acquisition of cancer hallmarks
  279. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks
  280. Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and …
  281. The hallmarks of cancer revisited through systems biology and network modelling
  282. Role and hallmarks of Sp1 in promoting ovarian cancer
  283. TRP channels and small GTPases interplay in the main hallmarks of metastatic cancer
  284. Hallmark of cancer: Evasion of growth suppressors
  285. Transportome malfunctions and the hallmarks of pancreatic cancer
  286. Redox Signaling: Hallmarks of Cancer Progression and Resistance to Treatment
  287. Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
  288. Hallmarks of splicing defects in cancer: clinical applications in the era of personalized medicine
  289. Tumor microenvironment indoctrination: an emerging hallmark of cancer
  290. Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
  291. A landscape of epigenetic regulation by MicroRNAs to the hallmarks of cancer and cachexia: implications of physical activity to tumor regression
  292. The gene regulatory network for breast cancer: integrated regulatory landscape of cancer hallmarks
  293. Aberrant RNA m6A modification in gastrointestinal malignancies: versatile regulators of cancer hallmarks and novel therapeutic opportunities
  294. Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer
  295. Our studies on aberrant glycosylation in oral cancer and insights on glycosylation as a hallmark of cancer
  296. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments
  297. A Missing Hallmark of Cancer: Dysregulation of Differentiation
  298. Viral G protein-coupled receptors as modulators of cancer hallmarks
  299. Using The Cancer Genome Atlas as a tool to improve undergraduate student understanding of cancer genetics and the hallmarks of cancer progression
  300. Multi-task topic analysis framework for hallmarks of cancer with weak supervision
  301. Targeting six hallmarks of cancer in ovarian cancer therapy
  302. Combating oxidative stress as a hallmark of cancer and aging: Computational modeling and synthesis of phenylene diamine analogs as potential antioxidant
  303. Hallmarks of cancer-focus on RNA metabolism and regulatory noncoding RNAs
  304. Updates of cancer hallmarks in patients with inborn errors of immunity
  305. Protein post-translational modifications in the regulation of cancer hallmarks
  306. A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis …
  307. Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
  308. Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and …
  309. Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis
  310. Analysis of the circadian regulation of cancer hallmarks by a cross-platform study of colorectal cancer time-series data reveals an association with genes involved in …
  311. The prodigious network of chromosome 17 miRNAs regulating cancer genes that influence the hallmarks of cancer
  312. Ubiquitin–proteasome system in the hallmarks of cancer
  313. Using Microscopy to Unravel the Hallmarks of Cancer Cells
  314. … by a granulomatous lesion after spontaneous regression and PD-1 blockade-induced regression: can epithelioid granuloma be a histological hallmark of cancer …
  315. Deciphering the code between air pollution and disease: The effect of particulate matter on cancer hallmarks
  316. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer
  317. Identification of cancer hallmarks based on the gene co-expression networks of seven cancers
  318. Hallmarks of cancer: Guided research toward cancer prevention and potential limitations in recent therapeutic interventions.
  319. Reiterating the emergence of noncoding RNAs as regulators of the critical hallmarks of gall bladder cancer
  320. Increased formate overflow is a hallmark of oxidative cancer
  321. Using the “Hallmarks of Cancer” as a framework for medical students and clinicians to understand oncogenesis
  322. Enhancing the performance of cancer text classification model based on cancer hallmarks
  323. Application of Hallmarks of Cancer Gene Signatures Reveals Novel Energetics-Associated Subtypes with Distinct Survival Outcomes in AML
  324. The New Dimension of the Renin-Angiotensin System in the Hallmarks of Cancer
  325. Heat shock proteins as novel cancer therapeutics: targeting the hallmarks of cancer
  326. Pan-cancer characterisation of microRNA with hallmarks of cancer reveals role of microRNA-mediated downregulation of tumour suppressor genes
  327. Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression
  328. ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation. Cancers 2021, 13, 203
  329. E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities
  330. The hallmarks of cancer: Fighting back
  331. The enigmatic helicase DHX9 and its association with the hallmarks of cancer
  332. Oncogenes, Signal Transduction and the Hallmarks of Cancer
  333. Hallmark of cancer: avoiding immune suppression
  334. Neem limonoids as anticancer agents: modulation of cancer hallmarks and oncogenic signaling
  335. CHG: a systematically integrated database of cancer hallmark genes
  336. Impact of diet and nutrition on cancer hallmarks
  337. A Current Perspectıve To The Hallmarks Of Cancer
  338. Redeployment of Placental Gene Programming: Can Invasive Placentation Molecular Switches Complement the Hallmarks of Cancer
  339. Fast repair of DNA radicals in the earliest stage of carcinogenesis suppresses hallmarks of cancer
  340. The Hallmarks of Pancreatic Cancer
  341. Role of the tumor microenvironment in cancer hallmarks and targeted therapy
  342. Extra-cellular vesicles carry proteome of cancer hallmarks
  343. Aberrant signaling pathways: hallmark of cancer cells and target for nanotherapeutics
  344. Plasmonic biosensing for label-free detection of two hallmarks of cancer cells: cell-matrix interaction and cell division
  345. 220P Annotating mammaprint and blueprint gene profile to the hallmarks of cancer and understanding the biology of mammaprint extreme risk groups
  346. tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application
  347. The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling
  348. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich
  349. Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events
  350. The Cellular Prion Protein and the Hallmarks of Cancer. Cancers 2021, 13, 5032
  351. Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer
  352. Bacteriotherapy: understanding bacterial species specialization based on the established hallmarks of cancer
  353. Plasma Membrane Ca2+ ATPase Isoform 4 (PMCA4) Has an Important Role in Numerous Hallmarks of Pancreatic Cancer
  354. The Hallmarks of Cancer
  355. Dietary Polyphenols and Sulforaphane: Impact on Hallmarks of Colon Cancer (P06-045-19)
  356. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor–positive breast cancer
  357. Establishing Consensus Annotation for the Hallmarks of Cancer
  358. Toluquinol, A Marine Fungus Metabolite, Inhibits Some of the Hallmarks of Cancer
  359. Silibinin affects transcription factors of cell cycle, apoptosis, angiogenesis and metastasis in breast cancer mice model: Targeting the hallmarks of cancer
  360. Data-driven hallmarks of cancer as a new paradigm for precision medicine: multi-omics and functional profiling in acute myeloid leukemia
  361. Review of hallmarks of prostate cancer (PCa)
  362. Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability
  363. Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks
  364. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks
  365. USP7-a crucial regulator of cancer hallmarks
  366. The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers
  367. The Hallmarks of Cancer: Becoming Independent
  368. Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?
  369. Genomic hallmarks and therapeutic implications of cancer cell quiescence
  370. Hallmarks of Cancer: Tumor Promoting Inflammation
  371. Identifying novel SMYD3 interactors on the trail of cancer hallmarks
  372. Immune response triggered by a novel molecular crosstalk of major hallmarks of cancer: Angiogenesis, mismatch repair, and immune pathways.
  373. Study of cancer hallmarks relevance using a cellular automaton tumor growth model
  374. Sirtuins and the hallmarks of cancer
  375. The Hallmarks of Prostate Cancer Stem Cells
  376. Understanding the Hallmark Characteristics of Cancer
  377. The Hallmarks of Cancer and Drug Discovery
  378. Abstract LB-004: Molecular hallmarks of cancer: Stemness
  379. CBMT-41. IMAGING A HALLMARK OF CANCER: HYPERPOLARIZED 13C-MAGNETIC RESONANCE SPECTROSCOPY CAN NON-INVASIVELY MONITOR TERT …
  380. Simulating the Hallmarks of Cancer Robert G. Abbott
  381. Testing the paradigm: cancer gene sets and the hallmarks of cancer.
  382. The HIF-1α as a potent inducer of the hallmarks in gastric cancer
  383. Impact of microRNA dynamics on cancer hallmarks: an oral cancer scenario
  384. 222 Dexamethasone Induces Mesenchymal Trans-differentiation and Promotes Hallmarks of Cancer in Glioblastoma
  385. MicroRNAs and the Hallmarks of Cancer
  386. Hallmarks of cancer stem cells in men associated cancers: a review.
  387. Imaging a hallmark of cancer: hyperpolarized [U-2H, U-13C]-glucose and hyperpolarized [1-13C]-dehydroascorbic acid can monitor TERT expression in gliomas
  388. Mental health as a clinical hallmark of cancer
  389. Proteomics mining of cancer hallmarks on a single‐cell resolution
  390. Metabolic hallmarks of cancer cells as targets for integrative therapies
  391. Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses
  392. Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review
  393. From the modeling of the inmune hallmarks of cancer to a black swan in biology
  394. Abstract SY12-02: Neural regulation of tumors and their microenvironment: Novel, actionable, hallmark of cancer
  395. Sirtuins and next generation hallmarks of cancer: cellular energetics and tumor promoting inflammation
  396. Understanding the role of miRNAs in the hallmarks of cancer using functional screens.
  397. Understanding the role of miRNAs in the hallmarks of cancer using functional screens
  398. P2. 15-01 Digital Pathology Uncovers Multi-Omic Hallmarks of Lung Cancer in Histopathology Images
  399. Role of the NLRP3 inflammasome: insights into cancer hallmarks
  400. The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
  401. Investigating small non-coding RNA regulating the hallmarks of cancer
  402. Tumor aneuploidy correlates with hallmarks of cancer
  403. Abstract P5-06-04: Synergistically elevated hallmarks of cancer induced in non-malignant human breast cells by mixtures of environmental chemicals
  404. Calculating the effectiveness of some important anticancer herbal compounds against the main hallmarks of cancer
  405. Consensus gene expression analysis to identify key hallmarks of cancer in malignant melanoma.
  406. Abstract A05: Cumulative risk, key characteristics of carcinogens, and hallmarks of cancer analysis for carcinogenic drinking water contaminants
  407. Viruses, bacteria and Hallmarks of Cancer. Self-sufficiency in growth signals.
  408. Phytosterols and phytostanols and the hallmarks of cancer: a meta-analysis of pre-clinical animal models
  409. Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer
  410. CBMT-32. IMAGING A HALLMARK OF CANCER: TERT EXPRESSION LEADS TO MRS-DETECTABLE METABOLIC REPROGRAMMING
  411. CANCER-ASSOCIATED FIBROBLASTS–INHABITANTS OF TUMOR, HOWEVER OBSCURE UNDERLYING THE HALLMARKS OF CANCER
  412. Abstract SY40-02: YAP/TAZ activity as hallmark of cancer: Biologic properties, upstream regulations, and downstream targets
  413. Intrinsic cell factors that influence tumourigenicity in cancer stem cells-towards hallmarks of cancer stem cells
  414. Targeting a Hallmark of Cancer: Simultaneous
  415. Osteopontin induces global changes in gene expression that reflect the six “hallmarks of cancer”
  416. Hallmarks in Colorectal Cancer: Reprogramming of Metabolic Pathways and Cancer Stem-Like Cells
  417. Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks?
  418. Transcriptome analysis of clock disrupted cancer cells reveals differential alternative splicing of cancer hallmarks genes
  419. Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks
  420. Downregulation of LRP/LR with siRNA inhibits several cancer hallmarks in lung cancer cells
  421. Identification of cancer hallmarks associated with benefit in advanced gastroesophageal adenocarcinoma patients treated with checkpoint blockade
  422. Activated Sumoylation Is a Hallmark Of Burkitt’s Lymphoma and MYC Driven Cancer Leading To Synthetic Lethal Interactions With Sumoylation Inhibitors
  423. Cell-free chromatin particles released into the microenvironment from dying tumor cells activate cancer hallmarks in surviving cells: a study in advanced squamous …
  424. A roadmap to immunotherapy: lesson from the hallmarks and signaling pathways of cancer
  425. Studying the capability of different cancer hallmarks to initiate tumor growth using a cellular automaton simulation. Application in a cancer stem cell context
  426. Abstract B1-19: Computable cancer hallmarks-The construction of novel computable biological network models reflecting causal mechanisms of cancer hallmarks
  427. Dissecting the genomic heterogeneity of cancer hallmarks’ acquisition with SLAPenrich
  428. The Role of Transglutaminase 2 (TG2) in Definition of Cancer Hallmarks
  429. 43 Natural Anticancer Products: Classified under the Cancer Hallmarks and the Available Evidence of their Anticancer Activities
  430. A [Pt (cis-1, 3-diaminocycloalkane) Cl2] analog exhibits hallmarks typical of immunogenic cell death inducers in model cancer cells
  431. Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
  432. Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
  433. The Overview of Lung Cancer In North America And East And Central Asia: Hallmarks, Genetics, Risk Factors, Epidemiology, Screening, Prevention and Treatments
  434. Inference of Molecular Subtypes of Uterine Corpus Endometrioid Carcinoma with Different Survival Based on Cancer Hallmarks-associated Long Non-Coding RNAs …
  435. Transcriptomic analyses of the adenoma-carcinoma sequence identify hallmarks associated with the onset of colorectal cancer
  436. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma
  437. The current landscape of 3D in vitro tumor models: what cancer hallmarks are accessible for drug discovery?
  438. Roles of TGF-β in cancer hallmarks and emerging onco-therapeutic design
  439. lncRNAs as hallmarks for individualized treatment of gastric cancer
  440. The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks
  441. Role of calcium signaling in prostate cancer progression: effects on cancer hallmarks and bone metastatic mechanisms
  442. Use of Arabidopsis thaliana as a model to understand specific carcinogenic events: Comparison of the molecular machinery associated with cancer-hallmarks …
  443. Green Synthesized Silver Nanoparticles of Myrtus communis L (AgMC) Extract Inhibits Cancer Hallmarks via Targeting Aldose Reductase (AR) and Associated …
  444. ADAM and ADAMTS Family of Metalloproteinases: Role in Cancer Progression and Acquisition of Hallmarks
  445. Cancer hallmarks define a continuum of plastic cell states between small cell lung cancer archetypes
  446. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells
  447. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung
  448. Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular …
  449. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key‐associated molecular hallmarks: MicroRNA cell specific …
  450. Identifying Associations between DCE-MRI Radiomic Features and Expression Heterogeneity of Hallmark Pathways in Breast Cancer: A Multi-Center …
  451. Direct and rapid detection of 5-hydroxymethylcytosine, a novel cancer hallmark in DNA, using electrochemical reaction

Related Posts

Shopping Cart
Scroll to Top